Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
avapritinib
3
×
biotech
3
×
blueprint medicines
boston blog main
boston top stories
eli lilly
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
boston
cancer
clinical trials
fda
genentech
indiana blog main
indiana top stories
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
roche
selpercatinib
thyroid cancer
aimmune therapeutics
alopecia areata
amarin
arena pharmaceuticals
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cadent therapeutics
cancer drugs
cancer immunotherapy
capmatinib
celgene
centers for disease control and prevention
centrexion therapeutics
colucid pharmaceuticals
concert pharmaceuticals
What
approval
blueprint
cancer
drug
fda
medicines
ret
address
approves
arena’s
bio
bounty
candidate
carries
certain
cig
comeback
companies
corner
currently
deals
delivered
designed
expressing
genetic
ipo
latest
life
little
marketing
moderna’s
muscle
number
pact
pass
regulatory
review
roche
roundup
science
Language
unset
Current search:
avapritinib
×
biotech
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More